Tseng LM - Search Results

1

Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.

Liu CY, Huang TT, Chen YT, Chen JL, Chu PY, Huang CT, Wang WL, Lau KY, Dai MS, Shiau CW, Tseng LM. Liu CY, et al. Among authors: tseng lm. EBioMedicine. 2019 Feb;40:263-275. doi: 10.1016/j.ebiom.2018.12.032. Epub 2019 Jan 14. EBioMedicine. 2019. PMID: 30651219 Free PMC article.

2

CIP2A is a target of bortezomib in human triple negative breast cancer cells.

Tseng LM, Liu CY, Chang KC, Chu PY, Shiau CW, Chen KF. Tseng LM, et al. Breast Cancer Res. 2012 Apr 26;14(2):R68. doi: 10.1186/bcr3175. Breast Cancer Res. 2012. PMID: 22537901 Free PMC article.

3

Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.

Liu CY, Tseng LM, Su JC, Chang KC, Chu PY, Tai WT, Shiau CW, Chen KF. Liu CY, et al. Among authors: tseng lm. Breast Cancer Res. 2013;15(4):R63. doi: 10.1186/bcr3457. Breast Cancer Res. 2013. PMID: 23938089 Free PMC article.

4

Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients.

Hung MH, Liu CY, Shiau CY, Hsu CY, Tsai YF, Wang YL, Tai LC, King KL, Chao TC, Chiu JH, Su CH, Lo SS, Tzeng CH, Shyr YM, Tseng LM. Hung MH, et al. Among authors: tseng lm. PLoS One. 2014 Feb 24;9(2):e89389. doi: 10.1371/journal.pone.0089389. eCollection 2014. PLoS One. 2014. PMID: 24586742 Free PMC article.

5

Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.

Liu CY, Su JC, Ni MH, Tseng LM, Chu PY, Wang DS, Tai WT, Kao YP, Hung MH, Shiau CW, Chen KF. Liu CY, et al. Among authors: tseng lm. Breast Cancer Res Treat. 2014 Jul;146(1):71-84. doi: 10.1007/s10549-014-3000-0. Epub 2014 Jun 6. Breast Cancer Res Treat. 2014. PMID: 24903225

6

Tamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cells.

Liu CY, Hung MH, Wang DS, Chu PY, Su JC, Teng TH, Huang CT, Chao TT, Wang CY, Shiau CW, Tseng LM, Chen KF. Liu CY, et al. Among authors: tseng lm. Breast Cancer Res. 2014 Sep 17;16(5):431. doi: 10.1186/s13058-014-0431-9. Breast Cancer Res. 2014. PMID: 25228280 Free PMC article.

7

Molecular characteristics of recurrent triple-negative breast cancer.

Tsai CH, Chiu JH, Yang CW, Wang JY, Tsai YF, Tseng LM, Chen WS, Shyr YM. Tsai CH, et al. Among authors: tseng lm. Mol Med Rep. 2015 Nov;12(5):7326-34. doi: 10.3892/mmr.2015.4360. Epub 2015 Sep 24. Mol Med Rep. 2015. PMID: 26458489 Free PMC article.

8

Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells.

Liu CY, Hu MH, Hsu CJ, Huang CT, Wang DS, Tsai WC, Chen YT, Lee CH, Chu PY, Hsu CC, Chen MH, Shiau CW, Tseng LM, Chen KF. Liu CY, et al. Among authors: tseng lm. Oncotarget. 2016 Feb 23;7(8):9135-49. doi: 10.18632/oncotarget.7035. Oncotarget. 2016. PMID: 26824320 Free PMC article.

9

Role of mitochondrial dysfunction in cancer progression.

Hsu CC, Tseng LM, Lee HC. Hsu CC, et al. Among authors: tseng lm. Exp Biol Med (Maywood). 2016 Jun;241(12):1281-95. doi: 10.1177/1535370216641787. Epub 2016 Mar 27. Exp Biol Med (Maywood). 2016. PMID: 27022139 Free PMC article. Review.

10

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.

Su JC, Mar AC, Wu SH, Tai WT, Chu PY, Wu CY, Tseng LM, Lee TC, Chen KF, Liu CY, Chiu HC, Shiau CW. Su JC, et al. Among authors: tseng lm. Sci Rep. 2016 Jul 1;6:28888. doi: 10.1038/srep28888. Sci Rep. 2016. PMID: 27364975 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page